Christina Vorvis is Director of East Coast Ventures at AbbVie Ventures, where she leads corporate venture investments across multiple therapeutic areas including oncology, immunology, neuroscience, eye care, and aesthetics rather than focusing on a single disease area. She combines a PhD in cancer biology with experience in digital health startups and investment banking to serve as AbbVie's on-the-ground corporate VC presence in the Massachusetts life sciences cluster, often taking board positions with portfolio companies like Xenimmune Therapeutics.